The Effects of SEA0400 on Ca2+Transient Amplitude and Proarrhythmia Depend on the Na+/Ca2+Exchanger Expression Level in Murine Models

Bögeholz N, Schulte JS, Kaese S, Bauer BK, Pauls P, Dechering DG, Frommeyer G, Goldhaber JI, Kirchhefer U, Eckardt L, Pott C, Müller FU

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

Background/Objective: The cardiac Na+/Ca2+exchanger (NCX) has been identified as a promising target to counter arrhythmia in previous studies investigating the benefit of NCX inhibition. However, the consequences of NCX inhibition have not been investigated in the setting of altered NCX expression and function, which is essential, since major cardiac diseases (heart failure/atrial fibrillation) exhibit NCX upregulation. Thus, we here investigated the effects of the NCX inhibitor SEA0400 on the Ca2+transient amplitude and on proarrhythmia in homozygous NCX overexpressor (OE) and heterozygous NCX knockout (hetKO) mice compared to corresponding wild-types (WTOE/WThetKO).Methods/Results:Ca2+transients of field-stimulated isolated ventricular cardiomyocytes were recorded with fluo-4-AM or indo-1-AM. SEA0400 (1 μM) significantly reduced NCX forward mode function in all mouse lines. SEA0400 (1 μM) significantly increased the amplitude of field-stimulated Ca2+transients in WTOE, WThetKO, and hetKO, but not in OE ({\%} of basal; OE = 98.7 ± 5.0; WTOE= 137.8 ± 5.2*; WThetKO= 126.3 ± 6.0*; hetKO = 140.6 ± 12.8*;*p< 0.05 vs. basal). SEA0400 (1 μM) significantly reduced the number of proarrhythmic spontaneous Ca2+transients (sCR) in OE, but increased it in WTOE, WThetKOand hetKO (sCR per cell; basal/+SEA0400; OE = 12.5/3.7; WTOE= 0.2/2.4; WThetKO= 1.3/8.8; hetKO = 0.2/5.5) and induced Ca2+overload with subsequent cell death in hetKO.Conclusion:The effects of SEA0400 on Ca2+transient amplitude and the occurrence of spontaneous Ca2+transients as a proxy measure for inotropy and cellular proarrhythmia depend on the NCX expression level. The antiarrhythmic effect of SEA0400 in conditions of increased NCX expression promotes the therapeutic concept of NCX inhibition in heart failure/atrial fibrillation. Conversely, in conditions of reduced NCX expression, SEA0400 suppressed the NCX function below a critical level leading to adverse Ca2+accumulation as reflected by an increase in Ca2+transient amplitude, proarrhythmia and cell death. Thus, the remaining NCX function under inhibition may be a critical factor determining the inotropic and antiarrhythmic efficacy of SEA0400.

Details zur Publikation

FachzeitschriftFrontiers in Pharmacology
Jahrgang / Bandnr. / Volume8
StatusVeröffentlicht
Veröffentlichungsjahr2017
Sprache, in der die Publikation verfasst istEnglisch
DOI10.3389/fphar.2017.00649
Link zum Volltexthttps://www.frontiersin.org/articles/10.3389/fphar.2017.00649/full

Autor*innen der Universität Münster

Bauer, Bastian Klemens
Department für Kardiologie und Angiologie
Bögeholz, Nils
Department für Kardiologie und Angiologie
Dechering, Dirk
Department für Kardiologie und Angiologie
Eckardt, Lars
Department für Kardiologie und Angiologie
Frommeyer, Gerrit
Department für Kardiologie und Angiologie
Kaese, Sven
Department für Kardiologie und Angiologie
Kirchhefer, Uwe
Institut für Pharmakologie und Toxikologie
Müller, Frank Ulrich
Institut für Pharmakologie und Toxikologie
Pott, Christian
Department für Kardiologie und Angiologie
Schulte, Jan Sebastian
Institut für Pharmakologie und Toxikologie